Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Andrew D. Campbell, MD
Comprehensive Sickle Cell Disease Program
Children's National Health System
111 Michigan Avenue, NW
Washington, DC, United States
Dr. Campbell’s distinguished training and career path began at Morehouse College. He continued medical school at Case Western Reserve University and completed post graduate training at Massachusetts General Hospital (Harvard) and Lurie Children’s Hospital (Northwestern University). Prior to joining Children’s National, he was Director of the Comprehensive Sickle Cell Center at the University of Michigan, a position he held since 2005. His research interests span several topics in sickle cell disease including pulmonary complications, fetal hemoglobin switching in transgenic sickle cell mice, phenotype/genotype relationships, and renal complications.
Areas of Interest:
Pulmonary Hypertension in sickle cell disease
Phenotype/genotype Studies within twin and siblings with sickle cell disease
Morbidity and mortality in transitioning sickle cell patients
Fetal hemoglobin switching within sickle cell trangenic mice
Onyinye Onyekwere, MDDr. Onyinye Onyekwere is a pediatric hem...
Sickle cell patients suffer as disparities in care and research persistWhen 9-year-old Jeremy Brown is in pai...
Hannah S. Lichtsinn, MDHannah S. Lichtsinn is MD in internal me...
Practice variation in emergency department management of children with sickle cell disease who present with feverOBJECTIVES:Urgent medical evaluation is ...
University of Pittsburgh Medical CenterPeople with inherited blood disorders re...
2019 Annual Sickle Cell Symposium – Sickle Cell: Past Present and FutureDRAFT Agenda 5:00pm Registration, netwo...
FDA Approves Novel Treatment to Target Abnormality in Sickle Cell DiseaseToday, the U.S. Food and Drug Administra...